As a Research Associate - Preclinical Vaccine Evaluation, you will be a pillar of our in vivo team. You will work hands-on in the lab and in the animal facility on mouse experiments, testing the immunogenicity and protective capacity of our vaccines. In close collaboration with the vaccine development team, your work will drive the selection and optimization of our lead program.
Join Baxiva and help shape the future of bacterial vaccines Baxiva is a biotechnology startup developing next-generation glycoconjugate vaccines to prevent infections caused by Gram-negative bacterial pathogens. Our lead vaccine candidate targets Escherichia coli, the leading cause of urinary tract infections worldwide, and a major contributor to antimicrobial resistance. Backed by cutting-edge science and operating in Schlieren and on ETH Zurich’s Hönggerberg campus, Baxiva offers a unique opportunity to contribute to high-impact science with real-world clinical potential.
